420 with CNW — Analysis Shows Ohio Stands to Collect

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
371
420 with CNW — Analysis Shows Ohio Stands to Collect $404M in Annual Cannabis Taxes

Ohio has the potential to witness a substantial boost in its yearly tax revenue, reaching an impressive $403.5 million from the sales of recreational marijuana, according to a fresh analysis by researchers at Ohio State University. The researchers base their tax revenue estimations on the initial years of sales, drawing insights from comparable markets in other states.

The study primarily hones in on the patterns of cannabis sales in Michigan, a neighboring state with a similar population size. Additionally, Michigan’s tax structure bears a striking resemblance to the one that Ohio would likely adopt if the legalization measure gets the nod. The research also casts its gaze on sales figures from 2018 to 2023 in states such as Washington, Oregon, Nevada, Illinois, and Colorado.

This report marks the second iteration, an update from last year’s edition, factoring in two more years of marijuana sales data in regulated markets. The decision to revise the estimates stems from the high likelihood of Ohio granting voters the opportunity to weigh in on the legalization initiative via the coming ballot.

The outcomes of this research indicate that Ohio could potentially rake in between $276.2 and $403.5 million in annual tax revenue from cannabis sales within five years of its legalization. Notably, the lower estimate remains consistent with the previous year’s report, while the upper range has surged by nearly $30 million due to the inclusion of more sales data from the six states.

This range in estimations results from the utilization of three distinct pricing models. The models map out the potential tax income under the following scenarios: Ohio’s cannabis products are taxed at rates equivalent to Michigan’s, 10% higher or 20% higher.

The paper underscores the pivotal role tax levels and structure would play in determining the final tax revenue. Although the Michigan tax framework and the proposed Ohio tax structure are comparatively modest among legalized states, Ohio could opt for higher taxes, potentially leading to enhanced revenue. Nevertheless, this could inadvertently elevate product costs, making it challenging to combat the illicit marijuana trade and potentially resulting in dwindling tax returns over time.

The report further elucidates that revenue from marijuana tends to exhibit robust growth during the initial stages of adult-use legalization, with a subsequent tapering off as markets mature. As evident from their review of different states, established markets have witnessed declines in cannabis tax revenue, while newer entrants such as Illinois and Michigan experienced significant revenue growth.

The updated analysis projects escalating marijuana revenue in Ohio, projecting figures as high as $218.5 million in the second year of sales, surging to potentially $305.6 million in the third year and $366.8 million in the fourth year. The peak is expected to be reached in the fifth year, hitting the $403.5 million milestone.

Throughout 2023, multiple states with legalized marijuana have reported consistently record-breaking monthly sales. Michigan, for instance, achieved a new monthly record in July, exceeding the previous month’s sales by a substantial margin.

States in the Northeast, including Rhode Island, Massachusetts, Maine and Connecticut, have all marked new records for marijuana transactions. Illinois recorded its strongest sales month to date in July, while Maryland also saw impressive figures since launching its recreational market. Missouri has also experienced a thriving cannabis market since its recreational market initiation in February, boasting daily sales averaging around $4 million and attaining a record-breaking $121.3 million in cannabis purchases in June.

In Ohio, proponents of cannabis legalization are confident about the initiative’s appearance on the ballot. Despite falling short by 679 signatures initially, advocates managed to bridge the gap during a 10-day correction period after submitting a substantial number of petitions. The campaign awaits official confirmation of success from the secretary of state’s office.

Once cannabis is legalized in Ohio, numerous business opportunities are likely to open up for a diverse variety of enterprises, such as Advanced Container Technologies Inc. (OTC: ACTX), which specialize in providing supplies like indoor cultivation equipment to mainstream marijuana companies.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer


Advanced Container Technologies Inc. (ACTX) Stock Research Links

ACTX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading

Top 5 Most Recently Viewed Articles

Introducing Vishay's Versatile Control Knobs for Any Application

Updated Category News Views 181

Enhancing User Experience with Vishay's New Control Knobs Vishay Intertechnology, Inc. (NYSE: VSH) has recently introduced a groundbreaking series of control knobs tailored to enhance usability across various applications. These new knobs are designed for use with Vishay’s extensive panel potentiometer portfolio, ensuring smooth operation whether you're using bare hands...

Continue Reading
Exciting Keynote Speakers Set for 2025 ACTFL Conference

Updated Category News Views 276

Exciting Keynote Speakers for the Upcoming ACTFL Convention ACTFL is thrilled to announce the lineup of keynote speakers for the highly anticipated 2025 Annual Convention and World Languages Expo. Renowned actor Miguel Cervantes, celebrated for his role as Alexander Hamilton in Broadway's Hamilton, will deliver the Opening Keynote address. Joining him is Dr. Steve Boyes,...

Continue Reading
Join the Excitement at the OpenSSL Conference 2025 Today

Updated Category News Views 114

Early Bird Registration Now Available for the OpenSSL Conference Excitement is building as the inaugural OpenSSL Conference approaches, allowing individuals deeply interested in cryptography and secure systems to come together. While the event is set for three days, from October 7 to October 9, 2025, early registrations are currently open. Attendees can seize the...

Continue Reading
Sampo plc’s Strategic Share Buybacks: Impacts and Insights

Updated Category News Views 217

Sampo plc’s Recent Share Buybacks Overview Sampo plc recently made headlines with its strategic share buybacks, reflecting a robust commitment to its shareholders and a proactive approach in strengthening its stock performance. This move is part of a broader trend among companies looking to enhance shareholder value amidst fluctuating market conditions. The Buyback...

Continue Reading
Investigation into Soleno Therapeutics: Investors Urged to Act

Updated Category News Views 177

Overview of the Investigation There is a growing interest among investors regarding the activities of Soleno Therapeutics, Inc. (NASDAQ: SLNO). Recently, a prominent law firm has initiated an investigation on behalf of stockholders to determine if there have been any violations of federal securities laws or unethical business practices by the company. Background on Soleno...

Continue Reading